Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.630
+0.080 (2.25%)
At close: Mar 9, 2026, 4:00 PM EDT
3.510
-0.120 (-3.31%)
After-hours: Mar 9, 2026, 6:52 PM EDT
MRVI Revenue
In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. Maravai LifeSciences Holdings had revenue of $49.87M in the quarter ending December 31, 2025, a decrease of -11.83%.
Revenue (ttm)
$185.74M
Revenue Growth
-28.34%
P/S Ratio
4.89
Revenue / Employee
$426,995
Employees
435
Market Cap
933.15M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortrea Holdings | 2.72B |
| Arvinas | 262.60M |
| Valneva SE | 211.09M |
| Geron | 183.88M |
| ARS Pharmaceuticals | 142.77M |
| uniQure | 16.10M |
| Arbutus Biopharma | 14.61M |
| Aktis Oncology | 5.56M |
MRVI News
- 11 days ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 4 weeks ago - Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Business Wire
- 4 months ago - Maravai LifeSciences Announces November 2025 Investor Conference Schedule - Business Wire
- 4 months ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Maravai LifeSciences Reports Third Quarter 2025 Financial Results - Business Wire
- 4 months ago - MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders - GlobeNewsWire
- 4 months ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 - Business Wire